Insider filing · ARWR
Mauro Ferrari
Director
profile →
Arrowhead Pharmaceuticals, Inc.
ARWR · Healthcare · 34 filings in 24 months
ticker →
Mauro Ferrari sold $527K of Arrowhead Pharmaceuticals (ARWR)
Executed Dec 26 2025, disclosed Dec 30 2025, 4 days later.
Value, as filed
$527K
7,530 sh × $70.00
Executed
Dec 26 2025
the trade date, as filed
Disclosed
Dec 30 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MFMauro Ferrari (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Arrowhead Pharmaceuticals, Inc. (ARWR). The largest single filing was $527K of ARWR (7,530 sh × $70.00, as filed), executed Dec 26 2025.
The name
ARWRHealthcare · Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mauro Ferrari in ARWR
ARWRSALE
Arrowhead Pharmaceuticals, Inc.
$493K8,750 sh × $56.39
Exec Nov 28 2025
Filed Dec 1 2025 · 5:30 PM ET